In conclusion, PD-1 and PD-L1 are two biomarkers of the TIME in rectal cancer which are clearly influenced by RT, mostly being upregulated by several cell types, and tending to an unfavorable immunosuppressive therapy response, as a negative side effect of RT (see Figure 3). The gene discussed is CD274; the disease is rectal cancer.